FOLLOW US

  • facebook
  • twitter
Sun

March 22, 2026

Shkrelis $64M Disgorgement rehearing

America October 7, 2024

Supreme Court Denies Shkreli’s $64M Disgorgement Rehearing

The U.S. Supreme Court declined on Monday to review former pharmaceutical executive Martin Shkreli’s challenge to a $64 million disgorgement…

By Rihem Akkouche

2nd Circ. Backs Shkreli Lifetime Pharma Industry Ban

America January 23, 2024

2nd Circ Backs Shkreli Lifetime Pharma Industry Ban

In a pivotal decision, the Second Circuit reaffirmed on Tuesday the lifetime ban on former pharmaceutical tycoon and convicted securities…

By Rihem Akkouche

Martin Shkreli picture

Business December 8, 2021

Vyera Pharmaceuticals to pay $40 million for illegally monopolizing Daraprim; Pharma Bro Martin Shrekli to face trial

Vyera Pharmaceuticals and its parent company Phoenixus AG (formerly Turing Pharmaceuticals) agreed to a $40 million settlement for illegally monopolizing…

By Marivic Cabural Summers

Martin Shkreli

Business January 27, 2020

FTC, New York AG Sued ‘Pharma Bro’ Martin Shkreli for “Illegally Monopolizing” Daraprim

The Federal Trade Commission (FTC) and New York Attorney General Letitia James filed a lawsuit against ‘Pharma Bro’ Martin Shkreli…

By Marivic Cabural Summers

Signup for the USA Herald
exclusive Newsletter